Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone in Children and Adolescents With Autistic Disorder
NCT00576732Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in Autism Spectrum Disorder (ASD), sponsored by Johnson & Johnson. Started Dec 2007; status: completed.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00576732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576732.